Novocure Accounts Payable from 2010 to 2025
| NVCR Stock | USD 25.51 0.01 0.04% |
Accounts Payable | First Reported 2013-12-31 | Previous Quarter 90.2 M | Current Value 91.3 M | Quarterly Volatility 28.9 M |
Check Novocure financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Novocure's main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.8 M, Interest Expense of 7.6 M or Selling General Administrative of 198.1 M, as well as many indicators such as Price To Sales Ratio of 3.41, Dividend Yield of 0.0 or PTB Ratio of 3.75. Novocure financial statements analysis is a perfect complement when working with Novocure Valuation or Volatility modules.
Novocure | Accounts Payable |
Latest Novocure's Accounts Payable Growth Pattern
Below is the plot of the Accounts Payable of Novocure over the last few years. An accounting item on the balance sheet that represents Novocure obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Novocure are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Novocure's Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Novocure's overall financial position and show how it may be relating to other accounts over time.
| Accounts Payable | 10 Years Trend |
|
Accounts Payable |
| Timeline |
Novocure Accounts Payable Regression Statistics
| Arithmetic Mean | 43,468,049 | |
| Geometric Mean | 28,824,814 | |
| Coefficient Of Variation | 88.85 | |
| Mean Deviation | 33,444,186 | |
| Median | 26,708,000 | |
| Standard Deviation | 38,620,878 | |
| Sample Variance | 1491.6T | |
| Range | 103.9M | |
| R-Value | 0.93 | |
| Mean Square Error | 221.4T | |
| R-Squared | 0.86 | |
| Slope | 7,529,098 | |
| Total Sum of Squares | 22373.6T |
Novocure Accounts Payable History
About Novocure Financial Statements
Novocure shareholders use historical fundamental indicators, such as Accounts Payable, to determine how well the company is positioned to perform in the future. Although Novocure investors may analyze each financial statement separately, they are all interrelated. The changes in Novocure's assets and liabilities, for example, are also reflected in the revenues and expenses on on Novocure's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Accounts Payable | 108.5 M | 114 M |
Additional Tools for Novocure Stock Analysis
When running Novocure's price analysis, check to measure Novocure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novocure is operating at the current time. Most of Novocure's value examination focuses on studying past and present price action to predict the probability of Novocure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novocure's price. Additionally, you may evaluate how the addition of Novocure to your portfolios can decrease your overall portfolio volatility.